REVASC

This brand name is authorized in Estonia.

Active ingredients

The drug REVASC contains one active pharmaceutical ingredient (API):

1	Desirudin UNII U0JZ726775 - DESIRUDIN
	Desirudin is a highly potent and selective inhibitor of free circulating and clot-bound thrombin. The anticoagulant properties of desirudin are demonstrated by its ability to prolong the clotting time of human or rat plasma whether induced directly (thrombin time) or via the intrinsic (aPTT) or extrinsic (PT) pathways.
	Read more about Desirudin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
REVASC Powder and solvent for solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B01AE01	Desirudin	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AE Direct thrombin inhibitors
Discover more medicines within B01AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1208371, 1208382, 1229149